Rarity

Los Angeles, United States

Rarity is a biotechnology company that offers genetic treatments for immune diseases.

$4.6M raised

Oct 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Rarity raised?

Rarity has raised $4.6M in total funding. The most recent round was Seed. The last funding was announced in October 2025.

Who are Rarity's investors?

Rarity's investors include Steve Oliveira.

Where is Rarity headquartered?

Rarity is headquartered in Los Angeles, United States.

What does Rarity do?

Rarity is a biotechnology company that offers genetic treatments for immune diseases.

What stage is Rarity at?

Rarity is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 29, 2025.

MLA

"Rarity — Funding & Investors." VCBacked, October 29, 2025, https://www.vcbacked.co/company/rarity. Accessed July 2, 2026.

APA

VCBacked. (2025). Rarity — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/rarity

Wikipedia (cite web)

{{cite web |title=Rarity — Funding & Investors |url=https://www.vcbacked.co/company/rarity |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 29, 2025.